Respuesta :
a) ERK normally phosphorylates the RTK and inhibits its signaling. Inhibition of RAF-V600E decreases ERK activity, which leads to increased RTK signaling play an important role in cancer.
The traditional RAS-RAF-MEK-ERK signaling pathway is preserved in mammals, and the mitogen-activated protein kinase (MAPK) signaling pathway is crucial for cellular biological processes. ARAF, BRAF, and CRAF are three members of the RAF family that bind to RAS, which acts as the upstream activator, and mediate the MAPK signaling transduction to MEK. With the aid of extracellular signals, RAS.GDP (inactive) is converted to RAS.GTP (active), which then initiates a number of downstream cascades, including the RAF/MEK/ERK pathway, to transmit the signal. Thirty percent of human cancers, such as melanoma, breast cancer, ovarian cancer, colon cancer, thyroid cancer, prostate cancer, and others, are linked to the hyperactivation of ERK signaling brought on by mutations in the genes encoding receptor tyrosine kinases, RAS, BRAF, CRAF, MEK1, or MEK2. Furthermore, BRAF and its RAS activator mutations are thought to be the primary cause of this pathway's dysregulation, and RAS mutations are linked to 27% of all human malignancies. It goes without saying that the MAPK pathway is frequently dysregulated in many cancers that harbor RAS mutations, leading to the pathway's constitutive activation, unchecked proliferation, and decreased cellular sensitivity to substances that could initially induce apoptosis.
Learn more about cancer
https://brainly.com/question/28212376
#SPJ4
Otras preguntas
